Factors concerning access to a potential drug consumption room in Dublin, Ireland

References

• Anoro, M., Ilundain, E., & Santisteban, O. (2003). Barcelona’s safer injection facility-EVA: A harm reduction program lacking official support. Journal of Drug Issues, 33, 689–712.10.1177/002204260303300309
   Web of Science ®Google Scholar
• Butler, S., & Mayock, P. (2005). ‘An Irish solution to an Irish problem’: Harm reduction and ambiguity in the drug policy of the Republic of Ireland. International Journal of Drug Policy, 16, 415–422.10.1016/j.drugpo.2005.07.002
   Web of Science ®Google Scholar
• Coleman, H., & Unrau, Y. A. (2011). Qualitative data analysis. In Y. A. Unrau & R. M. Grinnell (Eds.), Social work research and evaluation: Foundations of evidence-based practice (pp. 447–464). Oxford University Press.
   Google Scholar
• D’Arcy, C. (2017, September 12). Senior Garda questions process around drug injecting centre. Retrieved from www.irishtimes.com
   Google Scholar
• Duffin, T. (2016, December 24). It’s planned the first supervised injecting facility will open in 2017. So how did we get here? Retrieved from www.thejournal.ie
   Google Scholar
• European Monitoring Committee for Drugs and Drug Addiction. (2015). Perspectives on drugs – Drug consumption rooms: An overview of provision and evidence. Lisbon: Author.
   Google Scholar
• European Monitoring Committee for Drugs and Drug Addiction. (2016). European drug report: Trends and development. Lisbon: Author.
   Google Scholar
• Fry, C. L. (2002). Injecting drug user attitudes towards rules for supervised injecting rooms: Implications for uptake. International Journal of Drug Policy, 13, 471–476.10.1016/S0955-3959(02)00076-2
   Google Scholar
• Fry, C. L., Fox, S., & Rumbold, G. (1999). Establishing safe injecting rooms in Australia: Attitudes of injecting drug users. Australian and New Zealand Journal of Public Health, 23(5), 501–504.10.1111/j.1467-842X.1999.tb01306.x
   PubMed Web of Science ®Google Scholar
• Green, T. C. (2004). My place, your place, or a safer place: The intention among montreal injecting drug users to use supervised injecting facilities. Canadian Journal of Public Health, 95(2), 110–114.
   PubMed Web of Science ®Google Scholar
• Hedrich, D. (2004). European report on drug consumption rooms. Lisbon: EMCDDA.
   Google Scholar
• Hunt, N. (2006a). Paper B: The evaluation literature on drug consumption rooms. The report of the independent working group on drug consumption rooms. York: Joseph Rowntree Foundation.
   Google Scholar
• Hunt, N. (2006b). Paper C: An overview of models of delivery of drug consumption rooms. The report of the independent working group on drug consumption rooms. York: Joseph Rowntree Foundation.
   Google Scholar
• Kerr, T., Wood, E., Small, D., Palepu, A., & Tyndall, M. W. (2003). Potential use of safer injecting facilities among injection drug users in Vancouver’s Downtown Eastside. Canadian Medical Association Journal, 169(8), 759–763.
   PubMed Web of Science ®Google Scholar
• Kimber, J., & Dolan, K. (2007). Shooting gallery operation in the context of establishing a medically supervised injecting centre: Sydney, Australia. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 84(2), 255–266.10.1007/s11524-006-9145-3
   PubMed Web of Science ®Google Scholar
• Kimber, J., Dolan, K., & Wodak, A. (2005). Survey of drug consumption rooms: Service delivery and perceived public health and amenity impact. Drug and Alcohol Review, 24, 21–24.10.1080/09595230500125047
   PubMed Web of Science ®Google Scholar
• Moore, D. (2004). Governing street-based injecting drug users: A critique of heroin overdose prevention in Australia. Social Science & Medicine, 59, 1547–1557.10.1016/j.socscimed.2004.01.029
   PubMed Web of Science ®Google Scholar
• O’Shea, M. (2007). Introducing safer injecting facilities (SIFs) in the Republic of Ireland: ‘Chipping away’ at policy change. Drugs: Education, Prevention and Policy, 14(1), 75–88.
   Web of Science ®Google Scholar
• Potier, C., Laprévote, V., Dubois-Arber, F., Cottencin, O., & Rolland, B. (2014). Supervised injection services: What has been demonstrated? A systematic literature review. Drug and Alcohol Dependence, 145, 48–68.10.1016/j.drugalcdep.2014.10.012
   PubMed Web of Science ®Google Scholar
• Small, W., Ainsworth, L., Wood, E., & Kerr, T. (2011). IDU perspectives on the design and operation of North America’s first medically supervised injection facility. Substance Use & Misuse, 46, 561–568.10.3109/10826084.2010.517714
   PubMed Web of Science ®Google Scholar
• Small, W., Moore, D., Shoveller, J., Wood, E., & Kerr, T. (2012). Perceptions of risk and safety within injection settings: Injection drug users’ reasons for attending a supervised injecting facility in Vancouver, Canada. Health, Risk & Society, 14(4), 307–324.10.1080/13698575.2012.680950
   Web of Science ®Google Scholar
• Solai, S., Dubois-Arber, F., Benninghoff, F., & Benaroyo, L. (2006). Ethical reflections emerging during the activity of a low threshold facility with supervised drug consumption room in Geneva, Switzerland. International Journal of Drug Policy, 17, 17–22.10.1016/j.drugpo.2005.12.008
   Web of Science ®Google Scholar
• Strauss, A. L., & Corbin, J. M. (1990). Basics of qualitative research: Grounded theory procedures and techniques. Thousand Oaks, CA: Sage Publications.
   Google Scholar
• Watson, T. M., Bayoumi, A., Kolla, G., Penn, R., Fischer, B., Luce, J., & Strike, C. (2012). Police perceptions of supervised consumption sites (SCSs): A qualitative study. Substance Use & Misuse, 47, 364–374.10.3109/10826084.2011.645104
   PubMed Web of Science ®Google Scholar
• Watson, T. M., Strike, C., Penn, R., Jairam, J., Hopkins, S., Luce, J., … Mayoumi, A. M. (2013). Design considerations for supervised consumption facilities (SCFs): Preferences for facilities where people can inject and smoke drugs. International Journal of Drug Policy, 24, 156–163.10.1016/j.drugpo.2012.09.003
   PubMed Web of Science ®Google Scholar
• Zurhold, H., Degkwitz, P., Verthein, U., & Haasen, C. (2003). Drug consumption rooms in Hamburg, Germany: Evaluation of the effects on harm reduction and the reduction of public nuisance. Journal of Drug Issues, 33, 663–688.10.1177/002204260303300308
   Web of Science ®Google Scholar